Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ferrandina

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
Gynecologic Oncology|September 1, 1994
Combined use of CA 125 and CA 15-3 in patients with endometrial carcinomaG Scambia, A Gadducci, P B Panici, et al.
International Journal of Cancer|May 28, 1993
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell linesG Scambia, F O Ranelletti, P B Panici, et al.
Gynecologic Oncology|April 1, 1993
Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptorG Ferrandina, G Scambia, P Benedetti Panici, et al.
Cancer|March 15, 1990
Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignanciesG Scambia, P B Panici, S Iacobelli, et al.
Anticancer Research|November 1, 1989
Epidermal growth factor levels in human breast cyst fluidF Battaglia, S Rossi, G Scambia, et al.
Gynecologic Oncology|June 25, 2013
Ovarian cancer patients with localized relapse: clinical outcome and prognostic factorsM Petrillo, A Fagotti, G Ferrandina, et al.
British Journal of Cancer|October 1, 1996
Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinomaM Maurizi, G Almadori, G Ferrandina, et al.
British Journal of Cancer|May 14, 1998
Prognostic significance of methyl-p-hydroxy-phenyllactate-esterase activity in laryngeal squamous cell carcinomaM Maurizi, G Ferrandina, G Almadori, et al.
International Journal of Cancer|December 2, 1992
EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significanceM Maurizi, G Scambia, P Benedetti Panici, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancerG Scambia, P Benedetti Panici, E Foti, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
Gynecologic Oncology|September 1, 1994
Combined use of CA 125 and CA 15-3 in patients with endometrial carcinomaG Scambia, A Gadducci, P B Panici, et al.
International Journal of Cancer|May 28, 1993
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell linesG Scambia, F O Ranelletti, P B Panici, et al.
Gynecologic Oncology|April 1, 1993
Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptorG Ferrandina, G Scambia, P Benedetti Panici, et al.
Cancer|March 15, 1990
Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignanciesG Scambia, P B Panici, S Iacobelli, et al.
Anticancer Research|November 1, 1989
Epidermal growth factor levels in human breast cyst fluidF Battaglia, S Rossi, G Scambia, et al.
Gynecologic Oncology|June 25, 2013
Ovarian cancer patients with localized relapse: clinical outcome and prognostic factorsM Petrillo, A Fagotti, G Ferrandina, et al.
British Journal of Cancer|October 1, 1996
Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinomaM Maurizi, G Almadori, G Ferrandina, et al.
British Journal of Cancer|May 14, 1998
Prognostic significance of methyl-p-hydroxy-phenyllactate-esterase activity in laryngeal squamous cell carcinomaM Maurizi, G Ferrandina, G Almadori, et al.
International Journal of Cancer|December 2, 1992
EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significanceM Maurizi, G Scambia, P Benedetti Panici, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancerG Scambia, P Benedetti Panici, E Foti, et al.
Pageof 18